Sublingual Grass Pollen Tablets

Grastek tablets contain pollen allergen extract from timothy grass phleum pratense grastek is a sublingual tablet.

Sublingual grass pollen tablets.

A multicenter clinical trial of 473 adults in the united states. First dose in doctor s office starting at least 4 months prior to the start of grass pollen season. Ages 10 65 years old. Oralair is approved for use in persons 5 through 65.

Oralair is an allergen extract indicated as immunotherapy for the treatment of grass pollen induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen specific ige antibodies for any of the 5 grass species contained in this product. Grass pollen sublingual extract sweet vernal orchard perennial rye timothy kentucky blue oralair. Grastek is available as a tablet of 2800 bau of timothy grass pollen allergen extract. New sublingual immunotherapy tablet treats tree pollen allergy published online.

Patients were treated with oralair or placebo starting 4 months before the start of grass allergy season and for the duration of the pollen season. Read the medication guide provided by your pharmacist before you start taking this medication and each time you get a refill. The efficacy and safety of the 300 index of reactivity ir dose of 5 grass pollen sublingual immunotherapy slit tablets stallergènes antony france have been demonstrated for the treatment of hay fever in adults. Lauderdale florida 33334 in addition to being an author and principle investigator of the one the studies included di bona et al systematic review and meta analysis of grass pollen allergen sublingual immunotherapy slit.

One tablet once a day. We sought to assess the efficacy and safety of this tablet in children and adolescents with grass pollen related allergic rhinitis. Allergic rhinitis with or without allergic conjunctivitis. Grass pollen sublingual tablets benefits extend beyond clinical trial corresponding author.

1 combined score is a patient specific measure that combines symptom and medication scores. This study indicates that sublingual immunotherapy with the 5 grass pollen tablet is well tolerated and provides sustained effectiveness over 2 years in patients with different clinical profiles producing a significant decrease in allergic symptoms and a reduction in the use of symptomatic medication. Oralair is a 5 grass pollen allergy sublingual immunotherapy tablet.